F-35: Is America's Most Expensive Weapon of War the Ultimate Failure?
Jim Roche, then-Secretary of the Air Force, made an announcement on October 26, 2001, that all aviation enthusiasts had been waiting for: a winner had been picked to design and build the Joint Strike Fighter. The American people were assured the new jet would enter service in 2008 and be a high-performance replacement for the military’s aging airframes while only costing between $40 million and $50 million.
The F-35 has now entered an unprecedented seventeenth year of continuing redesign, test deficiencies, fixes, schedule slippages, and cost overruns. And it’s still not at the finish line. Numerous missteps along the way—from the fact that the two competing contractors, Lockheed Martin and Boeing, submitted “flyoff” planes that were crude and undeveloped “technology demonstrators” rather than following the better practice of submitting fully functional prototypes, to concurrent acquisition malpractice that has prevented design flaws from being discovered until after production models were built—have led to where we are now. According to the latest annual report from the Director, Operational Test & Evaluation (DOT&E), 263 “high priority” performance and safety deficiencies remain unresolved and unaddressed, and the developmental tests—essentially, the laboratory tests—are far from complete. If they complete the tests, more deficiencies will surely be found that must be addressed before the plane can safely carry our Airmen and women into combat.
Recommended: The Story of the F-52 Fighter.
Despite this, the F-35 Joint Program Office now intends to call—quite arbitrarily—an end to the plane’s development phase and developmental testing. Instead of completing the presently planned development work, the Program Office is now proposing to substitute a vaguely defined F-35 upgrade program called “continuous capability development and delivery (C2D2).” The DOT&E report states flatly that this plan, as proposed, is “not executable due to inadequate test resources” in the rapid timelines proposed.
It doesn’t require inside information to understand that the proposed plan is just a way to hide major development delays and cost overruns while facilitating increased annual production buys of incompletely developed F-35s. Twenty-three fully designed, fully combat-capable F-35s are supposed to begin the all-important—and more rigorous—operational testing before the end of 2018, yet it is impossible to fix the 263 known Priority 1 and 2 deficiencies in time to meet that schedule.
This clearly doesn’t bother the senior Pentagon officials who are pushing to move forward with production despite the unresolved deficiencies. Already, 235 of the deficiency-ridden aircraft have been nominally designated “combat ready” and delivered to active Air Force and Marine Corps squadrons. The consequences of this plan for safety and effective tactics in operational unit training, let alone combat, are unknown. Defense Department officials who approved cutting short the F-35’s development phase should, and hopefully will, be held accountable when the inevitable consequences in safety, combat effectiveness, and cost overruns emerge.
As initially advertised, and throughout the program’s development, taxpayers have been told this exorbitantly costly system is necessary to combat advanced future threats. However, testing results show that the planes already delivered cannot even effectively address the current threats. That’s a problem.
In September 2016 then-Air Force Secretary Deborah Lee James certified to Congress that the F-35As to be delivered in FY 2018 would have full combat capabilities. (James was referring to the Block 3F aircraft to be produced this year.) But according to the DOT&E report, the current much-delayed testing schedule means that won’t be possible—they’re not even close to combat-ready. Left unsaid in the report is the uncomfortable fact that the 359 F-35s funded before FY 2018 are also lacking combat capability.